0
Abstract: Slide Presentations |

PLEURAL EFFUSION PREDICTS POOR OUTCOMES IN HOSPITALIZED PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA: RESULTS FROM THE CAPO INTERNATIONAL COHORT STUDY FREE TO VIEW

Juan Guardiola, MD; Ervin H. Anaya, MD*; Bogdan Moldoveanu, MD; Julio A. Ramirez, MD; CAPO Investigators MD
Author and Funding Information

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Disorders, Louisville, KY


Chest


Chest. 2008;134(4_MeetingAbstracts):s65003. doi:10.1378/chest.134.4_MeetingAbstracts.s65003
Text Size: A A A
Published online

Abstract

PURPOSE:Between 20% and 50% of patients with community acquired pneumonia (CAP) will develop a parapneumonic effusion (PPE). The impact of a PPE on the clinical outcomes of hospitalized patients with CAP has not been fully evaluated. The aim of this study is to identify the effect of a PPE on four relevant outcomes of CAP.

METHODS:A secondary analysis was conducted of the Community-Acquired Pneumonia Organization (CAPO) database, which contains retrospectively collected data on patients with CAP from 43 hospitals in 12 countries from June 2001 to May 2007. PPE was defined as an accumulation of fluid on chest radiograph that develops during pneumonia. CAP clinical outcomes, length of stay (LOS), time to clinical stability (TCS), and failure were defined by IDSA/ATS guidelines. In-hospital mortality was defined as death during hospitalization. The logistic regression model was used to predict the probability of occurrence of outcomes for PPE.

RESULTS:A total of 3070 patients were included in the study. The mean ±SD age was 66 ±18 years (range: 18–102) and 38% were female. PPE was found in 554 (18%) patients. The effect of PPE on CAP clinical outcomes is shown in the following table.

CONCLUSION:This study shows that patients with a PPE have poor outcomes during hospitalization for CAP.

CLINICAL IMPLICATIONS:Further research is needed to evaluate physician compliance with current PPE treatment guidelines and if more aggressive management of PPE may improve clinical outcomes.

DISCLOSURE:Ervin Anaya, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543